| Biological Information | |
|---|---|
| Background Information: | Doxorubicin HCl is an anthracycline antibiotic chemotherapy drug that inhibits topoisomerase II by induction of double-stranded DNA breaks. Inhibits nucleic acid synthesis by intercalating with DNA, and induces apoptosis via p53 tumor suppressor protein accumulation. Commonly used to treat leukemias and Hodgkin's lymphoma, as well as various other cancers. Provided as 10 mg of dry powder. |
| Target Name: | Doxorubicin |
| Usage | |
| Product Type: | Control Ligands & Inhibitors |
| Application: | Drug Discovery & Development |
| Storage Conditions: | Store at ≤-20°C. Please avoid multiple freeze/thaw cycles. |
| Usage Disclaimer: | These products may be covered by issued US and/or foreign patents, patent application and subject to Limited Use Label License. Please visit discoverx.com/license for a list of products that are governed by limited use label license terms and relevant patent and trademark information. |
| Additional Information | |
| Brand: | DiscoverX |
Doxorubicin Hydrochloride
Doxorubicin Hydrochloride is an agonist for p53, and CDC25a degradation. This product is provided as 10 mg of dry powder.
Datasheets
92-1101 Datasheet
View Document